B. Stankoff et al., Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1)RNA levels in HIV-related cognitive impairment, EUR J NEUR, 6(6), 1999, pp. 669-675
Cerebrospinal fluid (CSF) and plasma HIV-1 RNA levels were prospectively me
asured by the Roche Amplicor Monitor polymerase chain reaction assay in 30
HIV-1 infected patients without central nervous system opportunistic infect
ions. All participants completed a global neuropsychological battery consis
ting of Mattis Dementia Rating Scale. Additional tests were used to better
characterize the type of cognitive changes with a specific reference to fro
ntal lobe function. The neuropsychological evaluation confirmed the subcort
ical pattern of cognitive dysfunction. CSP and plasma HIV-1 RNA levels were
significantly correlated. No correlation was detected with either blood or
CSF RNA levels and the global cognitive status, but when stratified in thr
ee cognitive subgroups, higher CSP HIV-1 RNA levels were observed in the mo
re cognitively impaired subjects. Our results provide further evidence that
plasma and CSF HIV-1 RNA level cannot be used as a reliable diagnostic mar
ker for HIV-1 associated cognitive disorders. Only longitudinal studies wil
l determine whether a high CSF HIV-1 level could be a risk factor for HIV-I
dementia. fur J Neurol 6:669-675 (C) 1999 Lippincott Williams & Wilkins.